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Main Points:  
• TRPM2 channel is critical for Aβ42induced microglial activation and generation of TNFα. 
• PKC/NOXmediated ROS generation and activation of the PYK2/MEK/ERK signaling 
pathway mediate Aβ42induced TRPM2 channel activation.  
 
Abstract 
Amyloid β (Aβ)induced neuroinflammation plays an important part in Alzheimer’s disease 
(AD). Emerging evidence supports a role for the TRPM2 channel in Aβinduced 
neuroinflammation, but how Aβ induces TRPM2 channel activation and this relates to 
neuroinflammation remained poorly understood. We investigated the mechanisms by which 
Aβ42 activates the TRPM2 channel in microglial cells and the relationships to microglial 
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activation and generation of TNFα, a key cytokine implicated in AD. Exposure to 10300 
nM Aβ42 induced concentrationdependent microglial activation and generation of TNFα 
that were ablated by genetically deleting (TRPM2KO) or pharmacologically inhibiting the 
TRPM2 channel, revealing a critical role of this channel in Aβ42induced microglial 
activation and generation of TNFα. Mechanistically, Aβ42 activated the TRPM2 channel via 
stimulating generation of ROS and activation of PARP1. Aβ42induced generation of ROS 
and activation of PARP1 and TRPM2 channel were suppressed by inhibiting PKC and 
NADPH oxidases (NOX). Aβ42induced activation of PARP1 and TRPM2 channel was also 
reduced by inhibiting PYK2 and MEK/ERK. Aβ42induced activation of PARP1 was 
attenuated by TRPM2KO and moreover, the remaining PARP1 activity was eliminated by 
inhibiting PKC and NOX, but not PYK2 and MEK/ERK.  Collectively, our results suggest 
that PKC/NOXmediated generation of ROS and subsequent activation of PARP1 play a role 
in Aβ42induced TRPM2 channel activation and TRPM2dependent activation of the 
PYK2/MEK/ERK signalling pathway acts as a positive feedback to further facilitate 
activation of PARP1 and TRPM2 channel. These findings provide novel insights into the 
mechanisms underlying Aβinduced ADrelated neuroinflammation. 
 
Keywords 
Aβ42; microglial activation; TNFα; TRPM2 channel; ROS; PARP1 
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1 INTRODUCTION 
Microglial cells, the resident immune cells in the central nervous system (CNS), have an 
important role in the physiology and diseases of the CNS (Colonna & Butovsky, 2017; Perry 
& Holmes, 2014; Salter & Beggs, 2014; Tay, Savage, Hui, Bisht, & Tremblay, 2017; Wolf, 
Boddeke, & Kettenmann, 2017). Under healthy conditions or in the resting state, microglial 
cells assume a characteristic ramified morphology and perpetually sentinel the surroundings 
with their fine cell processes. In response to injury or infection, they are transformed to the 
activated state with an amoeboid morphology and initiate immune response via receptors 
recognizing danger/pathogenassociated molecular patterns (DAMP/PAMP) molecules to 
restore normal tissue homeostasis. However, chronic or dysregulated microglial activation 
and excessive generation of proinflammatory mediators, such as tumour necrosis factorα 
(TNFα) and reactive oxygen species (ROS), can cause neuroinflammation (Colonna & 
Butovsky, 2017; Regen, HellmannRegen, Costantini, & Reale, 2017; Wolf et al., 2017). 
Accruing preclinical and clinical evidence supports that an increase in amyloidβ peptides 
(Aβ) due to an imbalance between generation and removal is an early and initiating factor in 
Alzheimer’s disease (AD), the most common cause of dementia (Hong et al., 2016; Mucke & 
Selkoe, 2012; Selkoe & Hardy, 2016). It is widely accepted that Aβ can induce 
neuroinflammation that contributes to AD (Colonna & Butovsky, 2017; Heneka et al., 2015; 
Heppner, Ransohoff, & Becher, 2015; Nayak, Roth, & McGavern, 2014; Perry & Holmes, 
2014; Prokop, Miller, & Heppner, 2013; Regen et al., 2017; Wolf et al., 2017).  
 
The transient receptor potential melastatinrelated 2 (TRPM2) protein forms a Ca
2+

permeable cationic channel that is gated by intracellular ADPribose (ADPR) and also 
potently activated by ROS via ADPRgenerating mechanisms (Jiang, Yang, Zou, & Beech, 
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2010). This channel is widely expressed in immune cells and important in normal immune 
responses and various diseases related to peripheral inflammation (Knowles, Li, & Perraud, 
2013; Syed Mortadza, Wang, Li, & Jiang, 2015). A previous study shows that the TRPM2 
channel mediates H2O2induced Ca
2+
 influx in monocyte cells that activates the Ca
2+

sensitive prolinerich tyrosine kinase PYK2 and downstream extracellular signalregulated 
kinase (ERK)dependent signalling pathways to induce generation of chemokine and 
ulcerative inflammation (Yamamoto et al., 2008). The TRPM2 channel in macrophage cells 
plays an important role in autoinflammatory and metabolic diseases by coupling particular 
crystal/liposomeinduced generation of ROS to activation of the NLRP3 inflammasome and 
generation of interleukin1β (Zhong et al., 2013). Several studies examined the role for the 
TRPM2 channel in macrophage cells in endotoxininduced generation of TNFα but the 
findings are rather specific to particular context or experimental conditions (Di et al., 2011; 
Haraguchi et al., 2012; Wehrhahn, Kraft, Harteneck, & Hauschildt, 2010).  
 
The expression of TRPM2 channel in microglial cells is also welldocumented (Haraguchi et 
al., 2012; Jeong, Kim, Lee, Jung, & Oh, 2017; Miyake et al., 2014; Mortadza, Sim, Stacey, & 
Jiang, 2017). Poly(ADPR) polymerase1 (PARP1) has a crucial role in ROSinduced 
generation of ADPR and TRPM2 channel activation (Jiang et al., 2010). There is evidence 
that activation of PARP1 is critical in Aβinduced microglial activation (Kauppinen et al., 
2011). Consistently with these findings, a recent study shows that genetic knockout of the 
TRPM2 expression strongly suppressed microglial activation in the APP/PS1 AD mice 
(Ostapchenko et al., 2015). However, the mechanisms by which Aβ peptides, particularly the 
neurotoxic Aβ42, activate the TRPM2 channel and its relationship to neuroinflammation 
remained poorly defined. TNFα is a major neurotoxic cytokine generated by microglial cells 
(Block, Zecca, & Hong, 2007; Doll, Rellick, Barr, Ren, & Simpkins, 2015; Heppner et al., 
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2015; Krabbe et al., 2017; Sedger & McDermott, 2014). Furthermore, studies have reported 
that generation of TNFα is increased prior to development of the histopathological 
hallmarks and colocalized with amyloid plaques in the AD mice and patients, and longterm 
expression of TNFα leads to neuronal death in the AD mice; these findings strongly support 
critical involvement of TNFα in Aβinduced neuroinflammation and AD (Liu & Hong, 2003; 
Montgomery et al., 2011; Montgomery et al., 2013; WyssCoray & Rogers, 2012). In the 
present study, we investigated the role of the TRPM2 channel in Aβ42induced microglial 
activation and generation of TNFα in microglial cells and the signalling mechanisms, 
through which Aβ42 induces TRPM2 channel activation. Our findings provide novel insights 
into the mechanisms underlying Aβinduced neuroinflammation.  
 
2 MATERIALS AND METHODS 
2.1 Materials 
All chemicals or reagents were obtained from SigmaAldrich unless specified otherwise. 
PJ34 was from Santa Cruz, DPQ from Calbiochem, GKT137831 and U0126 from Cayman 
Chemical, and CTC and PF431396 from Tocris, respectively. Aβ42 and Aβ421 were from 
Eurogentec and ChinaPepetides. Stock solutions were prepared according to the 
manufactures’ recommendations, aliquoted and kept at 20°C.  
 
2.2 Microglial cell preparation 
All experimental protocols, including those using mice, were approved by the University of 
Leeds Ethical Review Committee and carried out in accordance with the University of Leeds 
guidelines and procedure and conforming to the UK Home Office regulations. The TRPM2 
knockout (TRPM2KO) mice were generated in our previous study (Zou et al., 2013). 
Microglia cells were isolated from 13 day old wildtype (WT) and TRPM2KO C57BL/6 
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mice as detailed in our recent study (Mortadza et al., 2017). Cells were seeded in wells of 96
wells plates (Costar) at a density of 1.1 x 10
5
, 2.75 x 10
5
 and 3.5 x 10
5
 cells/ml for cell death, 
Ca
2+
 and ROS imaging, and ELISA assays, respectively, and on polyLlysine coated 
coverslips at 5 x 10
4
 cells/ml in wells of 24well plates (Costar) for immunostaining.  Cells 
were maintained in DMEM supplemented with 10% foetal bovine serum, 10 units/ml 
penicillin and 100 µg/ml streptomycin at 37°C in a humidified atmosphere of 5% CO2 for 48 
hr before use. 
 
2.3 Cell morphology characterization
This was performed 24 hr after cells were exposed to Aβ peptides (Aβ42 or Aβ421) at 
indicated concentrations. Images were captured using an Incucyte imaging system with a 10x 
object lens or an EVOS Cell Imaging System with a 40x object lens (Thermo Fisher 
Scientific). The cell morphology was characterized by computerassisted analysis of form 
factor and aspect ratio of individual cells as described in previous studies (Soltys, Ziaja, 
Pawlinski, Setkowicz, & Janeczko, 2001; Zanier, Fumagalli, Perego, Pischiutta, & De Simoni, 
2015). The form factor was calculated as reciprocal of circularity using the formula of 4π x 
area/perimeter
2
, with the highest value of 1.0 indicating a perfect circle and with value 
approaching 0 indicating an elongated shape. The aspect ratio is defined as the lengthto
width ratio, with the minimal value of 1.0 indicating a perfect circle. In experiments 
examining the effects of inhibitors, cells were treated at 37°C with indicated concentrations 
of inhibitors 30 min prior to and during exposure to Aβ42.  
 
2.4 Immunofluorescent imaging 
Cells were fixed with 4% paraformaldehyde dissolved in deionized water for 15 min and 
permeabilized in phosphate buffer saline (PBS) containing 0.1% Triton X100. Following 
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rinsing with PBS containing 0.5% Tween20, cells were incubated in PBS containing 5% 
goat serum for 30 min. Cells were incubated with primary mouse antiTNFα (Millipore) at a 
dilution of 1:400 or antiPAR antibody (Enzo) at 1:500 overnight at room temperature and, 
after extensive washing in PSBT, incubated with secondary fluorescein isothiocyanate
conjugated antimouse IgG antibody (Sigma; 1:1000) for 1 hr at room temperature. After 
washing with PBS and rinsing in water, coverslips were mounted using mounting reagent 
containing 4’,6diamidino2phenylindole (DAPI) (Life Technologies). Images were captured 
using an EVOS Cell Imaging System.  
 
2.5 Enzymelinked immunosorbent (ELISA) assay of TNFα release 
Cells in 96well plates were incubated within 50 l fresh culture media containing Aβ42 at 
indicated concentrations for 72 hr and the culture media were collected.  The TNFα 
concentrations in culture media was determined by TNFα ELISA kits according to the 
manufacturer’s instructions (Peprotech). In experiments studying the effects of inhibitors, 
cells were treated with the inhibitor at indicated concentrations at 37°C 30 min before and 
during exposure to Aβ42.  
 
2.6 Necrotic cell death assay 
This was performed using propidium iodide (PI) staining.  Cells in 96wells plates were 
treated with Aβ42 at indicated concentrations for 72 hr, and were costained by PI and 
Hoechst 33342 (Cell Signaling Technology) with a final concentration of 2 µg/ml and 5 
µg/ml, respectively.  Images were captured using an EVOS Cell Imaging System and 
analyzed using ImageJ.  Cell death was determined by PIstained cells as percentage of 
Hoechststained cells in three randomly chosen areas in each image.   
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2.7 Single cell Ca
2+
 imaging 
Cells in 96well plates were treated with Aβ peptides (Aβ42 or Aβ421) at indicated 
concentrations for 8 hr. Cells were loaded with 5 µg/ml Fluo4/AM (Life Technologies) at 
room temperature in standard bath solution (SBS in mM: 134 NaCl, 5 KCl, 0.6 MgCl2, 1.5 
CaCl2, 8 glucose and 10 HEPES, pH 7.4) as described in our recent study (Mortadza et al., 
2017). At the end of Fluo4/AM loading, cells were counterstained by 5 µg/ml Hoechst. 
Images were captured using an EVOS Cell Imaging System. Ca
2+
 freeSBS was used in some 
experiments. In experiments examining the effects of inhibitors, cells were treated at 37°C 
with the inhibitors at indicated concentrations, 30 min prior to and duration exposure to Aβ42.  
 
2.8 Measurement of ROS generation 
Cellular ROS generation was assayed using 2’,7’dichlorodihydrofluorescein diacetate 
(DCFHDA) as recently described (Mortadza et al., 2017) or CellROX Deep Red 
(Invitrogen).  Briefly, cells plated in 96well plates were treated with Aβ42 at indicated 
concentrations for 8 hr. Cells were washed with SBS before loaded with 20 µM DCFHDA 
or 5 µM CellROX Deep Red in SBS at 37°C for 30 min. At the end of staining, cells were 
counterstained with Hoechst at a final concentration of 5 µg/ml for 30 min.  Images were 
captured using an EVOS Cell Imaging System. In experiments studying the effects of 
inhibitors, cells were treated with inhibitors at 37°C 30 min prior to and during exposure to 
Aβ42.  
 
2.9 Data acquisition, presentation and statistical analysis 
All the experiments were performed using three to four independent cell preparations, in 
triplicates (three wells of cells) for each condition each time.  For single cell imaging, images 
of five areas in each well were captured by the EVOS system with fixed exposure time (500 
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ms) and light intensity (70% illumination), except the experiments shown in figure 10 
examining TRPM2KO cells, where images were captured using 80% illumination, and 75
100 cells were examined in each well. The fluorescence intensity in each cell was quantified 
using ImageJ and subtracted with the background fluorescence intensity in the same image. 
The data, where appropriately, are presented as mean ± standard error of mean (SEM) of the 
mean values from each independent experiment for each condition. Statistical analysis was 
performed using Student’s ttest for comparison between two groups and oneway ANOVA 
followed by post hoc Tukey’s test for comparison among multiple groups, with p < 0.05 
being significant. 
 
3 RESULTS 
 
3.1 Aβ42induced microglial activation and generation of TNFα are TRPM2dependent 
 
A majority of microglial cells in culture displayed a ramified rodlike morphology and a 
small number of cells a more ramified morphology with more extensive cell processes 
(Figure 1a), similar to what was previously reported (Lai, Dibal, Armitage, Winship, & Todd, 
2013). Exposure to an increasing concentration of Aβ42 (10300 nM) induced more microglial 
cells to adopt a morphology typically bearing a single large lamellipodia together with larger 
amoeboid forms, or larger somata and shorter and coarser processes (Figure 1a). To 
quantitatively evaluate such Aβ42induced effects, we performed computerassisted analysis 
of form factor and aspect ratio (as described in Materials and Methods), two geometric 
parameters commonly used to characterize cell morphology (Soltys et al., 2001; Zanier et al., 
2015). Both parameters exhibited widespread distribution (Figure 1b), indicating 
heterogeneity in cell morphology. Nonetheless, it is evident that the mean value of aspect 
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ratio was progressively reduced, whereas the mean value of form factor increased, with the 
Aβ42 concentration increasing (Figure 1c). In contrast with the noticeable change in cell 
morphology induced by 300 nM Aβ42, exposure to 300 nM Aβ421, a peptide with reversal 
amino acid sequence used as a negative control, resulted in no effect on cell morphology 
(Figure 1d and supplementary Figure 1). As introduced above, TNFα represents the major 
proinflammatory cytokine generated by microglial cells and Aβinduced generation of TNFα 
plays an important role in ADrelated neuroinflammation. We therefore performed 
immunofluorescent imaging to examine TNFα expression in individual microglial cells 48 hr, 
and ELISA assay to determine TNFα release into the culture medium 72 hr, after exposure 
to Aβ42. Exposure to 10300 nM Aβ42 induced a concentrationdependent increase in both 
TNFα expression (Figure 1ef) and TNFα release by WT microglial cells (Figure 1g). 
Taken together, these results provide clear evidence to demonstrate that Aβ42 at 
pathologically relevant concentrations induces microglial activation and generation of TNFα. 
 
Previous studies provide evidence to support that activation of PARP1 is critical for Aβ
induced or traumatic brain injuryinduced microglial activation (Kauppinen et al., 2011; 
Stoica et al., 2014) and also for ROSinduced TRPM2 channel activation (Jiang et al., 2010).  
Furthermore, a recent study shows that TRPM2KO prevented Aβinduced microglial 
activation in the APP/PS1 AD mice (Ostapchenko et al., 2015).  It is somewhat anticipated 
but yet there was no evidence to show that the TRPM2 channel plays a role in Aβ42induced 
microglial activation. We therefore examined the effects of TRPM2KO and pharmacological 
inhibition of the TRPM2 channel on Aβ42induced microglial activation. There was no 
difference in microglial cells isolated from WT and TRPM2KO mice as reported in our 
previous study (Ye et al., 2014), displaying very similar ramified rodlike morphology 
(Figure 2ac).  In stark contrast with the remarkable change in the morphology of WT 
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microglial cells, exposure to Aβ42 up to 300 nM induced no significant change in the 
morphology of TRPM2KO microglial cells (Figure 2ac). Aβ42induced change in the 
morphology of WT microglial cells was prevented with treatment, prior to and during 
exposure to Aβ42, with 100 M 2APB, a TRPM2 channel inhibitor or 1 M PJ34, a PARP 
inhibitor (Jiang et al., 2010). These results from genetic and pharmacological interventions 
provide consistent evidence to show a critical role for the TRPM2 channel in determining 
Aβ42induced microglial activation. 
 
We were prompted to investigate whether the TRPM2 channel was also required for Aβ42
induced generation of TNFα. As described above, exposure to 30300 nM Aβ42 induced a 
strong and concentrationdependent increase in the TNFα expression in WT microglial cells, 
but the same treatment induced no detectable increase in the TNFα expression in TRPM2
KO microglial cells (Figure 3ab). Consistently, there was no Aβ42induced TNFα release 
from TRPM2KO microglial cells (Figure 3c). Aβ42induced TNFα release from WT 
microglial cells was strongly suppressed by treatment with 2APB, PJ34 or DPQ, another 
PARP inhibitor (Figure 3d). It has been recently shown that ROSinduced activation of the 
TRPM2 channel can cause microglial cell death via necrosis (Mortadza et al., 2017). 
However, PI staining showed that exposure to Aβ42 up to 300 nM for 72 hr, the longest 
treatment used for TNFα release, induced no significant necrotic cell death (supplementary 
Figure 2), largely ruling out the possibility that Aβ42induced TNFα release results from loss 
of membrane integrity accompanied with necrotic cell death. These results provide 
compelling evidence to indicate a critical role for the TRPM2 channel in Aβ42induced 
generation of TNFα as well as microglial activation. 
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3.2 Aβ42 activates the TRPM2 channel via promoting generation of ROS and activation of 
PARP1  
 
To seek mechanistic insights into the TRPM2 channel in Aβ42induced microglial activation 
and generation of TNFα, we were interested in the mechanisms by which Aβ42 activates the 
TRPM2 channel. As shown in previous studies (Jeong et al., 2017; Kraft et al., 2004; Miyake 
et al., 2014; Mortadza et al., 2017), TRPM2 channel activation in microglial cells mediates 
extracellular Ca
2+
 influx leading to an increase in the [Ca
2+
]c.  We therefore using single cell 
Ca
2+
 imaging using Fluo4, a fluorescent Ca
2+
 indicator, the method used in our recent study 
examining Zn
2+
induced TRPM2 channel activation in microglial cells (Mortadza et al., 
2017), to determine whether Aβ42 can induce TRPM2 channel activation by monitoring Aβ42
induced Ca
2+
 responses.  In extracellular Ca
2+
containing solution, exposure to 10300 nM 
Aβ42 for 8 hr led to a concentrationdependent increase in the [Ca
2+
]c (Figure 4a and 
supplementary Figure 3a), whereas exposure to 300 nM Aβ421 for 8 hr elicited no Ca
2+
 
response (supplementary Figure 3bc). Aβ42induced increase in the [Ca
2+
]c was not observed 
in extracellular Ca
2+
free solution (Figure 4bc). Furthermore, 30100 nM Aβ42 failed to 
induce any significant increase in the [Ca
2+
]c in TRPM2KO microglial cells (Figure 4de). 
Aβ42induced increase in the [Ca
2+
]c in WT microglial cells were also abolished by treatment 
with PJ34 or 2APB (Figure 4fg). Taken together, these results consistently support that 
Aβ42 induces TRPM2 channel activation in microglial cells. 
 
We hypothesized that Aβ42 induces TRPM2 channel activation via promoting generation of 
ROS and activation of PARP1, resulting in generation of ADPR, the TRPM2 channel 
activator. To testify this hypothesis, we firstly performed single cell imaging using DCF, a 
fluorescent indicator of cellular ROS. Exposure to 10300 nM Aβ42 for 8 hr led to a salient 
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and concentrationdependent increase in DCF fluorescence intensity, indicating Aβ42induced 
generation of ROS (Figure 5ab). Similar results were also obtained using CellROX Deep 
Red, another fluorescent indicator of cellular ROS (Figure 5c and supplementary Figure 4). 
Our previous study suggests involvement of the TRPM2 channel in ischemia/reperfusion
induced generation of ROS (Ye et al., 2014). Here, we examined the role of TRPM2 channel 
in Aβ42induced generation of ROS in microglial cells. Aβ42induced generation of ROS was 
significantly reduced but not completely abolished by TRPM2KO (supplementary Figure 5). 
We next examined Aβ42induced activation of PARP1 by immunofluorescent imaging of 
poly(ADPR) or PAR, the product of PARP1. Exposure to 100 nM Aβ42 resulted in massive 
generation of PAR in WT microglial cells, which was predominantly concentrated in the 
nucleus as illustrated by colocalization with DAPI counterstaining (Figure 5de). These 
observations are highly consistent with engagement of PARP1, the major PARP isoform in 
the nucleus (Kauppinen & Swanson, 2007). Aβ42 also induced generation of considerable 
PAR in TRPM2KO microglial cells, which was however significantly lower than that in WT 
microglial cells (Figure 5fg). As anticipated, generation of PAR in both WT and TRPM2
KO cells was completely prevented by treatment with PJ34, prior to and during exposure to 
Aβ42 (Figure 5fg). These results, taken together with the abovedescribed observation that 
Aβ42induced TRPM2mediated increase in the [Ca
2+
]c was abolished by treatment with PJ34 
(Figure 4), support that Aβ42 activates the TRPM2 channel via inducing generation of ROS 
and subsequent activation of PARP1. 
 
3.3 PKC/NOXmediated generation of ROS is critical in Aβ42induced TRPM2 channel 
activation, microglial activation and generation of TNFα 
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NADPH oxidases (NOX) in microglial cells have a significant role in generation of ROS in 
AD and other neurodegenerative conditions (Block et al., 2007; Cheret et al., 2008; Harrigan, 
Abdullaev, Jourd'heuil, & Mongin, 2008).  Microglial cells are shown to express NOX1, 
NOX2 and NOX4 (Cheret et al., 2008; Harrigan et al., 2008). In addition, protein kinase C 
(PKC) and NOX have been reported for gangliosideinduced microglial activation (Min et al., 
2004) and microglial cell death after prolonged exposure to Zn
2+
 (Mortadza et al., 2017). We 
were interested in, and used the same treatments described in our recent study to examine 
whether PKC and NOX were importantly involved in Aβ42induced generation of ROS that 
leads to activation of PARP1 and TRPM2 channel. Treatment, prior to and duration 
exposure to Aβ42, with 3 M CTC, a PKC inhibitor, or 3 M DPI, a generic NOX inhibitor, 3 
M GKT, a NOX1/4 inhibitor or 30 M Phox, a NOX2 inhibitor, strongly inhibited Aβ42
induced generation of ROS (Figure 6a and d), activation of PARP1 (Figure 6b and e) and 
TRPM2mediated increase in the [Ca
2+
]c (Figure 6c and f). Such treatments also blocked 
Aβ42induced microglial activation (Figure 7ad). Furthermore, treatment with 13 M CTC, 
DPI or GKT and 30 M Phox strongly suppressed Aβ42induced generation of TNFα 
(Figure 7e). These results thus strongly indicate a critical role for PKC/NOX in Aβ42induced 
generation of ROS and activation of PARP1 and TRPM2 channel, providing further 
evidence to support the role of TRPM2 channel in Aβ42induced microglial activation and 
generation of TNFα.  
 
3.4 The PYK2/MEK/ERK signalling pathway acts a positive feedback in Aβ42induced 
activation of PARP1 and TRPM2 channel, microglial activation and generation of TNFα  
 
TRPM2mediated Ca
2+
 influx was previously showed to activate the PYK2/MEK/ERK 
pathway in ROSinduced generation of chemokine by monocyte cells (Yamamoto et al., 
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2008). We moved to examine whether such a signalling pathway participated in Aβ42induced
microglial activation and generation of TNFα. Treatment with 1 M PF, a PYK2 inhibitor, 
or 3 M U0126, a MEK/ERK inhibitor, largely prevented Aβ42induced microglial activation 
(Figure 8ab). In addition, treatment with 0.11 M PF or 13 M U0126 strongly inhibited 
Aβ42induced generation of TNFα (Figure 8c). These results provide clear evidence to 
suggest that the PYK2/MEK/ERK signalling pathway is important in Aβ42induced
microglial activation and generation of TNFα. 
 
It is known that activation of ERK can stimulate the PARP1 activity (Domercq et al., 2013; 
Kauppinen et al., 2006).  Treatment with 1 M PF or 3 M U0126 strongly inhibited Aβ42
induced activation of PARP1 (Figure 9ab) and TRPM2mediated increase in the [Ca
2+
]c 
(Figure 9cd), supporting a role for the PYK2/MEK/ERK signalling pathway in Aβ42induced 
activation of PARP1 and TRPM2 channel. We have recently reported that activation of this 
signalling pathway serves as a positive feedback mechanism to facilitate activation of PARP
1 and TRPM2 channel in microglial cell death induced by prolonged exposure to Zn
2+
 
(Mortadza et al., 2017). Aβ42induced activation of PARP1 in TRPM2KO microglial cells 
was blunted by inhibiting PKC with CTC or NOX with DPI, GKT or Phox (Figure 10ad), 
but unaffected by blocking PYK2 or MEK/ERK with PF and U0126, respectively (Figure 
10ef). These results are consistent with the notion that the PYK2/MEK/ERK signalling 
pathway as a mechanism downstream of the TRPM2 channel further enhances activation of 
PARP1 and TRPM2 channel (Figure 11). 
 
4 DISCUSSION 
Our study provides evidence to demonstrate a critical role for the TRPM2 channel in Aβ42
induced microglial activation and generation of TNFα. We show that PKC/NOXmediated 
Page 51 of 86
John Wiley & Sons, Inc.
GLIA
18 
 
generation of ROS and activation of PARP1 are required for Aβ42induced TRPM2 channel 
activation and, furthermore, the PYK2/MEK/ERK signalling pathway as a positive feedback 
mechanism downstream of TRPM2 channel activation facilitates further activation of PARP
1 and TRPM2 channel (Figure 11). These molecular and signalling mechanisms are also 
important in Aβ42induced microglial activation and generation of TNFα. Our findings thus 
provide novel insights into the mechanisms underlying Aβinduced neuroinflammation.  
 
It has been well recognized that Aβ causes neuroinflammation via inducing microglial 
activation and generation of excessive proinflammatory cytokines, thereby contributing to 
AD (Heneka et al., 2015; Heppner et al., 2015). Here we confirmed that Aβ42 at 
pathologically relevant concentrations induced microglial activation (Figure 1ad). In 
addition, Aβ42induced microglial activation (Figure 2de) and generation of nuclear PAR 
(Figure 5ef) were strongly inhibited by PJ34, consistent with the reported role of PARP1 in 
Aβinduced microglial activation (Kauppinen et al., 2011). In this study, we further showed 
that Aβ42induced microglial activation was prevented by TRPM2KO (Figure 2ac) or 
inhibition of the TRPM2 channel (Figure 2de). These observations, together with a recent 
finding that TRPM2KO suppressed microglial activation in the APP/PS1 AD mice 
(Ostapchenko et al., 2015), strongly support a critical role for the TRPM2 channel in Aβ42
induced microglial activation.  
 
Aβinduced microglial activation via activating the TRPM2 channel has been implicated in 
AD (Ostapchenko et al., 2015), but evidence supporting the role for the TRPM2 channel in 
Aβinduced neuroinflammation is still lacking. As introduced above, it has been well
documented that TNFα is potent in inducing neurotoxicity and that Aβinduced generation 
of TNFα from microglial cells significantly contributes to neuroinflammation in AD (Alam 
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et al., 2016; Block et al., 2007; Doll et al., 2015; Heppner et al., 2015; Krabbe et al., 2017; 
Liu & Hong, 2003; Montgomery et al., 2011; Montgomery et al., 2013; WyssCoray & 
Rogers, 2012). The present study showed that Aβ42 induced generation of TNFα by 
microglial cells (Figure 1eg). Importantly, we showed that such generation was strongly 
suppressed by TRPM2KO (Figure 3ac) and inhibiting the TRPM2 channel with 2APB, or 
inhibiting PARP1 with PJ34 and DPQ (Figure 3d), thus providing compelling evidence for 
the first time to demonstrate a critical role of the TRPM2 channel in Aβ42induced generation 
of TNFα. Considering the wellknown neurotoxicity of TNFα, our finding suggests, 
although further investigations are required to substantiate, a significant role of Aβ42induced 
TRPM2dependent generation of TNFα in AD pathogenesis.   
 
In the present study, we showed that Aβ42 induced TRPM2 channel activation (Figure 4). We 
further demonstrated that activation of PKC and NOX, including NOX1/4 and NOX2, and 
NOXmediated generation of ROS are important in Aβ42induced TRPM2 channel activation 
(Figure 6) as well as microglial activation and generation of TNFα (Figure 7).  Activation of 
these molecular mechanisms has been recently shown to be vital in TRPM2 channel 
activation induced by prolonged exposure to Zn
2+
 (Mortadza et al., 2017). Two recent studies 
have reported that LPS/IFNγ and LPC can induce TRPM2 channel activation but the 
activation mechanisms remain to be established (Jeong et al., 2017; Miyake et al., 2014). 
Regardless, the previous and present studies provide increasing evidence to support a 
widespread role for the TRPM2 channel in coupling diverse DAMP/PAMP molecules to an 
increase in the [Ca
2+
]c in microglial cells.  A previous study shows that TRPM2mediated 
Ca
2+
 influx in monocyte cells activates the PYK2/MEK/ERK signalling pathway in ROS
induced generation of chemokine (Yamamoto et al., 2008). Our recent study suggests such a 
signalling pathway acts as a positive feedback mechanism downstream of the TRPM2 
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channel to further enhance activation of PARP1 and TRPM2 channel in microglial cells in 
response to prolonged exposure to Zn
2+
 (Mortadza et al., 2017). In the present study, we 
showed that the PYK2/MEK/ERK signalling pathway is also critical in Aβ42induced 
microglial activation and generation of TNFα (Figure 8) as well as TRPM2 channel 
activation in microglial cells (Figure 9). TRPM2KO significantly attenuated but did not 
completely prevent Aβ42induced generation of ROS (supplementary figure 5), as previously 
reported in ischemia/reperfusioninduced generation of ROS in hippocampal neurons (Ye et 
al., 2014). Further investigations are required to understand the underlying mechanisms. 
Similarly, Aβ42induced activation of PARP1 depends on the TRPM2 channel because 
TRPM2KO also significantly reduced Aβ42induced activation of PARP1 (Figure 5fg). The 
remaining Aβ42induced PARP1 activity in TRPM2KO microglial cells was totally 
abolished by inhibiting PKC/NOX (Figure 10ad) but not PYK2/MEK/ERK (Figure 10ef). 
These differentiating results support the notion that Aβ42induced PKC/NOXmediated 
generation of ROS and activation of PARP1 plays a significant role in initiating TRPM2 
channel activation and subsequently the PYK2/MEK/ERK signalling pathway is fed back to 
activation of PARP1 to further enhance TRPM2 channel activation (Figure 11).  
 
In conclusion, we show a critical role for the TRPM2 channel in Aβ42induced microglial 
activation and generation of TNFα. We further reveal that PKC/NOXmediated generation 
of ROS and activation of PARP1 are required for Aβ42induced TRPM2 channel activation 
and the PYK2/MEK/ERK signalling pathway as a positive feedback mechanism further 
stimulates activation of PARP1 and TRPM2 channel. These novel findings provide 
mechanistic insights into Aβinduced neuroinflammation in AD pathogenesis.  
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Figure Legend 
Fig. 1 Aβ42 induces morphological changes and generation of TNFα in microglial cells 
(a) Representative phasecontrast images showing microglial cell morphology in culture 
without (CTL) or with exposure to Aβ42 at indicated concentrations for 24 hr, captured using 
an Incucyte imaging system with a 10x object lens (top) and an EVOS imaging system with a 
40x object lens (bottom). (b, c) Scatter plot showing the distribution of form factor and aspect 
ratio values of individual microglial cells (b), and mean form factor (top) and aspect ratio 
(bottom) values for microglial cells treated with the conditions shown in (a), from 4 
independent cell preparations. (d) Mean form factor (top) and aspect ratio (bottom) values of 
microglial cells without or with exposure to 300 nM Aβ42 or 300 nM Aβ421 for 24 hr, from 3 
independent cell preparations. (e) Representative immunofluorescent images showing TNFα 
expression in individual microglial cells without (CTL) and with exposure to Aβ42 at 
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indicated concentrations for 48 hr. Cells were counterstained with DAPI. (f) Summary of 
TNFα expression in microglial cells under the conditions shown in (e), from 3 independent 
cell preparations. (g) Summary of TNFα release determined by ELISA from microglial cells 
after exposed to Aβ42 at indicated concentrations for 72 hr from 4 independent cell 
preparations. Scale bar: 200 µm (a, top), 50 µm (a, bottom) and 40 µm (e).  *, p < 0.05; **, p 
< 0.01; ***, p < 0.005 compared to control. 
 
Fig. 2 TRPM2 is required for Aβ42induced microglial activation 
(a) Representative phasecontrast images showing single cell morphology of WT and 
TRPM2KO microglial cells without (CTL) or with exposure to Aβ42 at indicated 
concentrations for 24 hr, captured using an EVOS imaging system with a 40x object lens. (b, 
c) Scatter plot showing the distribution of form factor and aspect ratio values of individual 
microglial cells (b), and mean form factor (top) and aspect ratio (bottom) values for 
microglial cells under the conditions indicated in (a), from 4 independent cell preparations. (d, 
e) Scatter plot showing the distribution of form factor and aspect ratio values of individual 
WT microglial cells (d), and mean form factor (left) and aspect ratio (right) values for 
microglial cells without (CTL) or with exposure to 100 nM Aβ42 for 24 hr alone or treatment 
with 1 M PJ34 or 100 M 2APB, 30 min prior to and duration exposure to Aβ42 (e), from 
4 independent cell preparations. Scale bar: 50 µm.  ***, p < 0.005 compared to control. ###, 
p < 0.005 compared between WT and TRPM2KO cells under the same treatment (c), or 
compared to cells exposed to Aβ42 alone (e). 
 
Fig. 3 TRPM2 is important for Aβ42induced generation of TNFα by microglial cells 
(a) Representative immunofluorescent images showing TNFα expression in individual 
microglial cells from WT and TRPM2KO mice without (CTL) or with exposure to Aβ42 at 
Page 62 of 86
John Wiley & Sons, Inc.
GLIA
29 
 
indicated concentrations for 48 hr. Cells were counterstained with DAPI. (b) Summary of 
TNFα expression in microglial cells under the conditions indicated in (a), from 3 
independent cell preparations. (c) Summary of TNFα release determined by ELISA from 
WT and TRPM2KO microglial cells without or with exposure to Aβ42 at indicated 
concentrations for 72 hr, from 4 independent cell preparations. (d) Summary of TNFα 
release from microglial cells after exposure to 100 nM Aβ42 for 72 hr alone or treatment with 
1 M PJ34 or 100 M 2APB, 30 min prior to and during exposure to Aβ42, from 3 
independent cell preparations. Scale bar: 40 µm. *, p < 0.05; ***, p < 0.005 compared to 
control. #, p < 0.05; ##, p < 0.01; ###, p < 0.005 compared between WT and TRPM2KO 
cells under the same treatment (b, c) and cells exposed to Aβ42 alone (d). 
 
Fig. 4 Aβ42 induces Ca
2+
 influx and cytosolic Ca
2+
 increase through TRPM2 channel 
activation 
(a) Summary of the Fluo4 fluorescence intensity, indicative of the cytosolic Ca
2+
 levels, in 
WT microglial cells without (CTL) or with exposure to Aβ42 at indicated concentrations for 8 
hr, from 3 independent cell preparations using 3 wells of cells for each condition in each time. 
(b, d, f) Representative single cell Fluo4 fluorescent images showing the cytosolic Ca
2+
 
levels (top row: Fluo4 fluorescence; bottom row: counterstaining with Hoechst) in WT 
microglial cells without (CTL) or with exposure to 100 nM Aβ42 for 8 hr in extracellular 
Ca
2+
containing (+Ca
2+
) or Ca
2+
free (Ca
2+
) solutions (b), in WT and TRPM2KO microglial 
cells without (CTL) or with exposure to Aβ42 at indicated concentrations (d), or in WT 
microglial cells after exposure to 100 nM Aβ42 for 8 hr alone or treatment with 1 M PJ34 or 
100 M 2APB, 30 min prior to and during exposure to Aβ42 (f). (c, e, g) Summary of the 
mean cytosolic Ca
2+
 levels in microglial cells under conditions indicated in (b, d, f), from 3 
independent cell preparations. Scale bar: 40 µm. *, p < 0.05; ***, p < 0.005 compared to 
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control. ##, p < 0.01; ###, p < 0.005 ###, between cells exposed to Aβ42 in the presence and 
absence of Ca
2+
 in extracellular solutions (c), between WT and TRPM2KO cells under the 
same treatment (e), or between cells without or with treatment with PJ34 or 2APB.  
 
Fig. 5 Aβ42 induces generation of cellular ROS and activation of PARP1 in microglial 
cells 
(a) Representative single cell DCF fluorescence images showing cellular ROS generation 
(top row: DCF fluorescence; bottom row: counterstaining with Hoechst) in microglial cells 
without (CTL) or with exposure to Aβ42 at indicated concentrations for 8 hr. (b) Summary of 
Aβ42induced ROS generation in microglial cells under conditions shown in (a), from 3 
independent cell preparations. (c) Summary of Aβ42induced ROS production using Cell
ROX Deep Red in microglial cells under conditions shown in (a), from 3 independent cell 
preparations.  (d, f) Representative immunofluorescent images showing generation of PAR 
(top row) and counterstaining with DAPI (bottom row) in individual microglial cells without 
(CTL) or with exposure to 100 nM Aβ42 for 8 hr (d), or after exposure to with 100 nM Aβ42 
for 8 hr alone or treatment with 1 M PJ34 in WT and KOTRPM2 microglial cells, 30 min 
prior to and during exposure to Aβ42 (f). (e, g) Summary of Aβ42induced generation of PAR 
in microglial cells under indicated conditions from 3 independent cell preparations. Scale bar: 
40 µm. *, p < 0.05; **, p < 0.01; ***, p < 0.005 compared to control. ##, p < 0.01 compared 
between WT and TRPM2KO cells under the same treatment. 
 
Fig. 6 PKC and NOX are involved in Aβ42induced generation of ROS, activation of 
PARP1 and TRPM2 channel activation 
(a, d) , representative single cell DCF fluorescence images showing cellular ROS 
generation (top row: DCF fluorescence; bottom row: counterstaining with Hoechst) in 
Page 64 of 86
John Wiley & Sons, Inc.
GLIA
31 
 
microglial cells after exposure for 8 hr to 100 nM Aβ42 alone or treatment with 3 µM 
chelerythrine chloride (CTC) (a), 3 µM diphenyleneiodonium (DPI), 3 µM GKT137831 
(GKT) or 30 µM PhoxI2 (Phox) (d). , summary of Aβ42induced ROS generation in 
microglial cells under indicated conditions, from 3 independent cell preparations. (b, e) , 
representative immunofluorescent images showing PAR generation (top row) and 
counterstaining with DAPI (bottom row) in individual microglial cells after exposure for 8 hr 
to 100 nM Aβ42 alone or treatment with CTC (b), DPI, GKT or Phox (e). , Summary of 
Aβ42induced PAR generation in microglial cells under indicated conditions from 3 
independent cell preparations. (c, f) , representative single cell Fluo4 fluorescence images 
showing the cytosolic Ca
2+
 levels in microglial cells treated with indicated conditions (top 
row: Fluo4 fluorescence; bottom row: counterstaining with Hoechst). , summary of 
Aβ42induced Ca
2+
 responses in microglial cells under indicated conditions, from 3 
independent cell preparations. Cells were treated with inhibitors, 30 min prior to and during 
exposure to Aβ42. Scale bar: 40 m. ***, p < 0.005 compared to control.  ###, p < 0.005 
compared to cells exposed to Aβ42 alone. 
 
Fig. 7 Activation of PKC and NOX is vital in Aβ42induced microglial activation and 
generation of TNFα  
(a, c) Scatter plot showing the distribution of form factor and aspect ratio values of individual 
microglial cells after exposure for 24 hr to 100 nM Aβ42 alone or treatment with 3 µM CTC 
(a), 3 µM DPI, 3 µM GKT or 30 µM Phox (c), 30 min prior to and during exposure to Aβ42.  
(b, d) Summary of the mean form factor (top) and aspect ratio (bottom) values for microglial 
cells under indicated conditions from 3 independent cell preparations. (e) Summary of TNFα 
release determined by ELISA from microglial cells without (CTL) or with exposure to 100 
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nM Aβ42 alone or treatment with inhibitors at indicated concentrations from 3 independent 
cell preparations. Cells were treated with inhibitors, 30 min prior to and during exposure to 
Aβ42. ***, p < 0.005 compared to control. ##, p < 0.01; ###, p < 0.005 compared to cells 
exposed to Aβ42 alone. 
  
Fig. 8 The PYK2/MEK/ERK signalling pathway is critically involved in Aβ42induced 
microglial cell activation and generation of TNFα  
(a, b) Scatter plot showing the distribution of form factor and aspect ratio values of individual 
microglial cells (a), or mean form factor (left) and aspect ratio (right) values for microglial 
cells (b) without (CTL) or with exposure for 24 hr to 100 nM Aβ42 alone or treatment with 1 
M PF 431396 (PF) or 3 µM U0126, 30 min prior to and during exposure to Aβ42, from 3 
independent cell preparations. (c) Summary of TNFα release determined by ELISA from 
microglial cells without (CTL) or with exposure for 72 hr to 100 nM Aβ42 alone or treatment 
with PF or U0126 at indicated concentrations, 30 min prior to and during exposure to 100 nM 
Aβ42, from 3 independent cell preparations . ***, p < 0.005 compared to control. ###, p < 
0.005 compared to cells exposed to Aβ42 alone. 
 
Fig. 9 The PYK2/MEK/ERK signalling pathway is important in Aβ42induced activation 
of PARP1 and TRPM2 channel   
(a, b) , representative immunofluorescent images showing PAR generation (top row: 
PAR staining fluorescence; bottom row: counterstaining with DAPI) in microglia cells after 
exposure for 8 hr to 100 nM Aβ42 alone or treatment with 1 M PF (a) or 3 µM U0126 (b). 
, summary of Aβ42induced PAR generation in microglial cells treated with conditions 
shown on the left, from 3 independent cell preparations. (c, d) , representative single cell 
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Fluo4 fluorescence images showing the cytosolic Ca
2+
 levels (top row: Fluo4 fluorescence; 
bottom row: counterstaining with Hoechst) in microglial cells after exposure to 100 nM Aβ42 
without or with treatment with 1 M PF (c) or 3 µM U0126 (d). , summary of Aβ42
induced cytosolic Ca
2+
 responses in microglial cells under indicated conditions, from 3 
independent cell preparations. Scale bar: 40 m.  ***, p < 0.005 compared to control. ###, p 
< 0.005 compared to cells exposed to Aβ42 alone. 
 
Fig. 10 PKC and NOX are responsible for Aβ42induced activation of PARP in TRPM2
KO microglial cells 
(af) , representative immunofluorescent images showing PAR generation (top row: PAR 
staining fluorescence; bottom row: counterstaining with DAPI) in TRPM2KO microglia 
cells after exposure for 8 hr to 100 nM Aβ42 alone or treatment with 3 M CTC (a), 3 M 
DPI (b), 3 M GKT (c), 30 M Phox (d), 1 M PF (e) or 3 µM U0126 (f).  , summary 
of PAR generation in microglial cells under indicated conditions, from 3 independent cell 
preparations. Scale bar, 40 µm. ***, p < 0.005 compared control. ###, p < 0.005 compared to 
cells exposed to Aβ42 alone. 
 
Fig.11 Schematic summary of the mechanisms underlying Aβ42induced TRPM2 
channel activation in microglial cells leading to microglial activation of generation of 
TNFα 
Exposure to Aβ42 induces activation of protein kinase C (PKC) and NADPH oxidases (NOX), 
including NOX1/4 and NOX2, leading to generation of ROS. ROS stimulate activation of 
p(ADPribose) polymerase1 (PARP1) in the nucleus to generate ADPribose (ADPR). 
ADPR activates the TRPM2 channel, resulting extracellular Ca
2+
 influx to increase the 
cytosolic Ca
2+
 concentrations ([Ca
2+
]c). Intracellular Ca
2+
 stimulates the PYK2/MEK/ERK 
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signalling pathway to further enhance activation of PARP1 and TRPM2 channel.  TRPM2 
channel activation is required for Aβ42induced microglial activation and generation of 
tumour necrosis factor (TNF)α, a key proinflammatory cytokine implicated in 
neuroinflammation in Alzheimer’s disease. 
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Supporting information 
  
A critical role of TRPM2 channel in Aβ42induced microglial activation and generation 
of tumour necrosis factorα 
Sharifah Alawieyah Syed Mortadza, Joan A Sim, Veronika E Neubrand and LinHua Jiang
 
 
Figure legend  
 
Fig. 1 Control peptide Aβ421 induces no change in microglial cell morphology  
 representative phasecontrast images showing cell morphology of microglial cells 
without (CTL) or with exposure for 24 hr to 300 nM Aβ42 (a) or 300 nM Aβ421 (b), captured 
using an EVOS image system with a 40x object lens. Scale bar, 50 µm.  scatter plot 
showing the distribution form factor and aspect ratio values for individual microglial cells 
under indicated conditions, from 3 independent experiments using 3 well of cells for each 
conditions in each time. 
 
Fig. 2 Exposure to Aβ42 induces no microglial cell death 
(a) Representative fluorescent images showing propidium iodide (PI) staining of microglial 
cell death without (CTL) or with exposure to Aβ42 at indicated concentrations for 72 hr (top 
row: PIstained dead cells; bottom row: all cells stained with Hoechst).(b) Summary of mean 
percentage of PIpositive cells, from 3 independent experiments using 3 wells of cells for 
each condition in each time.  
 
Fig. 3 Control peptide Aβ421 induces no Ca
2+
 response in microglial cells 
(a) Representative single cell Fluo4 fluorescence images showing the cytosolic Ca
2+
 levels in 
microglial cells without (CTL) or with exposure to Aβ42 at indicated concentrations for 8 hr 
(top row: Fluo4 fluorescence; bottom row: counterstaining with Hoechst). (b) Representative 
single cell Fluo4 fluorescence images showing the cytosolic Ca
2+
 levels in microglial cells 
(top row: Fluo4 fluorescence; bottom row: counterstaining with Hoechst) without (CTL) or 
with exposure for 8 hr to 300 nM Aβ42 (left) or 300 nM Aβ421 (right). (c) Summary of the 
mean Ca
2+
 responses in microglial cells under indicated conditions, from 3 independent 
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experiments using 3 wells of cells for each condition in each time. Scale bar: 40 µm. ***, p < 
0.005 compared to control. 
 
Fig. 4 Aβ42 induced generation of ROS in microglial cells 
Representative single cell CellROX fluorescent images of showing cellular ROS production 
(top row: CellROX fluorescence; bottom row: counterstaining with Hoechst) in WT 
microglial cells without (CTL) or with exposure to Aβ42 at indicated concentrations for 8 hr.  
 
Fig. 5 TRPM2 channel in Aβ42induced ROS generation in microglial cells 
(a) Representative single cell CellDOX fluorescence images showing cellular ROS 
production (top row: CellROX fluorescence; bottom row: counterstaining with Hoechst) in 
WT and KOTRPM2 microglial cells without (CTL) or with exposure to Aβ42 at indicated 
concentrations for 8 hr. (b) Summary of Aβ42induced ROS production in microglial cells 
under conditions shown in (a) from 3 wells of cells (in triplicate) for each condition. Scale 
bar: 40 µm. *, p < 0.05; **, p < 0.01; ***, p < 0.005 compared to control. ##, p < 0.01; ###, p 
< 0.005 compared between WT and TRPM2KO cells under the same treatment. 
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